Our Science

We are the first company to clinically develop an Educated Mesenchymal Cell (EMC) therapy, designed to be more effective at treating immune disorders relative to competing therapies



Our Team

Our team has diverse skills and expertise, and it is unified in its drive to providing patients with better treatment options

research_stethoscope.jpg

jlabs_wide.png


Updates

April 1, 2019: Immplacate transitions from SUNY Downstate Biotech Incubator to JLABS NYC


Our Vision